Philipp Weber

Philipp Weber is a passionate and driven bioprocess engineer specializing in the digitalization of pharmaceutical processes. They gained valuable experience as an intern in various roles, including at Novo Nordisk, where they focused on digital twins, and Byondis, where they developed a continuous virus inactivation process for monoclonal antibodies. Philipp has also contributed to research at Harvard University and served as an academic tutor at the Karlsruher Institut für Technologie. Currently, they are pursuing a Master of Business Administration at Frankfurt School of Finance & Management while working as a Junior Scientist in the Synthetic Molecules Department at Roche.